Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT

Por Aksay, Suna Su, Hausner, Lucrezia, Frölich, Lutz, Sartorius, Alexander
Publicado no Neuropsychiatr Dis Treat (2014)

Development of a Proxy-Free Objective Assessment Tool of Instrumental Activities of Daily Living in Mild Cognitive Impairment Using Smart Home Technologies

Por Jekel, Katrin, Damian, Marinella, Storf, Holger, Hausner, Lucrezia, Frölich, Lutz
Publicado no J Alzheimers Dis (2016)

Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in p...

Por Frölich, Lutz, Wunderlich, Glen, Thamer, Claus, Roehrle, Michael, Garcia, Miguel, Dubois, Bruno
Publicado no Alzheimers Res Ther (2019)

A combined electrophysiological and morphological examination of episodic memory decline in amnestic mild cognitive impairment

Por Hoppstädter, Michael, King, Andrea Victoria, Frölich, Lutz, Wessa, Michèle, Flor, Herta, Meyer, Patric
Publicado em 2013

Case report: a giant arachnoid cyst masking Alzheimer’s disease

Por Wahl, Anna-Sophia, Löffler, Martin, Hausner, Lucrezia, Ruttorf, Michaela, Nees, Frauke, Frölich, Lutz
Publicado no BMC Psychiatry (2019)

Using Voxel-Based Morphometry to Examine the Relationship between Regional Brain Volumes and Memory Performance in Amnestic Mild Cognitive Impairment

Por Meyer, Patric, Feldkamp, Hanna, Hoppstädter, Michael, King, Andrea V., Frölich, Lutz, Wessa, Michèle, Flor, Herta
Publicado em 2013

Crossed Cerebellar Diaschisis in Alzheimer’s Disease Detected by Arterial Spin-labelling Perfusion MRI

Por HERTEL, ALEXANDER, WENZ, HOLGER, AL-ZGHLOUL, MANSOUR, HAUSNER, LUCREZIA, FRÖLICH, LUTZ, GRODEN, CHRISTOPH, FÖRSTER, ALEX
Publicado no In Vivo (2021)

Phenserine Efficacy in Alzheimer’s disease

Por Winblad, Bengt, Giacobini, Ezio, Frölich, Lutz, Friedhoff, Lawrence T., Bruinsma, Gosse, Becker, Robert E., Greig, Nigel H.
Publicado no J Alzheimers Dis (2010)

Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch

Por Molinuevo, José L, Frölich, Lutz, Grossberg, George T, Galvin, James E, Cummings, Jeffrey L, Krahnke, Tillmann, Strohmaier, Christine
Publicado no Alzheimers Res Ther (2015)

Tablet-based sensorimotor home-training system for amnestic mild cognitive impairments in the elderly: design of a randomised clinical trial

Por Bekrater-Bodmann, Robin, Löffler, Annette, Silvoni, Stefano, Frölich, Lutz, Hausner, Lucrezia, Desch, Simon, Kleinböhl, Dieter, Flor, Herta
Publicado no BMJ Open (2019)

Occupational exposure to low frequency magnetic fields and dementia: a case–control study

Por Seidler, Andreas, Geller, Petra, Nienhaus, Albert, Bernhardt, Tanja, Ruppe, Ingeburg, Eggert, Siegfried, Hietanen, Maila, Kauppinen, Timo, Frölich, Lutz
Publicado em 2007

Quality of Life as an outcome in Alzheimer's disease and other dementias- obstacles and goals

Por Riepe, Matthias W, Mittendorf, Thomas, Förstl, Hans, Frölich, Lutz, Haupt, Martin, Leidl, Reiner, Vauth, Christoph, Schulenburg, Matthias Graf von der
Publicado em 2009

Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer’s disease clinical program

Por Cummings, Jeffrey L., Atri, Alireza, Ballard, Clive, Boneva, Neli, Frölich, Lutz, Molinuevo, José Luis, Raket, Lars Lau, Tariot, Pierre N.
Publicado no Alzheimers Res Ther (2018)

Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease

Por Ballard, Clive, Atri, Alireza, Boneva, Neli, Cummings, Jeffrey L., Frölich, Lutz, Molinuevo, José Luis, Tariot, Pierre N., Raket, Lars Lau
Publicado no Alzheimers Dement (N Y) (2019)

Evaluation of Sodium (23Na) MR-imaging as a Biomarker and Predictor for Neurodegenerative Changes in Patients With Alzheimer’s Disease

Por MOHAMED, SHERIF A., HERRMANN, KATRIN, ADLUNG, ANNE, PASCHKE, NADIA, HAUSNER, LUCREZIA, FRÖLICH, LUTZ, SCHAD, LOTHAR, GRODEN, CHRISTOPH, KERL, HANS ULRICH
Publicado no In Vivo (2021)

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials

Por Atri, Alireza, Frölich, Lutz, Ballard, Clive, Tariot, Pierre N., Molinuevo, José Luis, Boneva, Neli, Windfeld, Kristian, Raket, Lars L., Cummings, Jeffrey L.
Publicado no JAMA (2018)

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease

Por Brinkmalm, Ann, Brinkmalm, Gunnar, Honer, William G, Frölich, Lutz, Hausner, Lucrezia, Minthon, Lennart, Hansson, Oskar, Wallin, Anders, Zetterberg, Henrik, Blennow, Kaj, Öhrfelt, Annika
Publicado no Mol Neurodegener (2014)

Separating Symptomatic Alzheimer’s Disease from Depression based on Structural MRI

Por Klöppel, Stefan, Kotschi, Maria, Peter, Jessica, Egger, Karl, Hausner, Lucrezia, Frölich, Lutz, Förster, Alex, Heimbach, Bernhard, Normann, Claus, Vach, Werner, Urbach, Horst, Abdulkadir, Ahmed
Publicado no J Alzheimers Dis (2018)

Drug development in Alzheimer’s disease: the path to 2025

Por Cummings, Jeffrey, Aisen, Paul S., DuBois, Bruno, Frölich, Lutz, Jack, Clifford R., Jones, Roy W., Morris, John C., Raskin, Joel, Dowsett, Sherie A., Scheltens, Philip
Publicado no Alzheimers Res Ther (2016)

On the path to 2025: understanding the Alzheimer’s disease continuum

Por Aisen, Paul S., Cummings, Jeffrey, Jack, Clifford R., Morris, John C., Sperling, Reisa, Frölich, Lutz, Jones, Roy W., Dowsett, Sherie A., Matthews, Brandy R., Raskin, Joel, Scheltens, Philip, Dubois, Bruno
Publicado no Alzheimers Res Ther (2017)